399 related articles for article (PubMed ID: 27765556)
1. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
Al Kasab S; Lynn MJ; Turan TN; Derdeyn CP; Fiorella D; Lane BF; Janis LS; Chimowitz MI;
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):108-115. PubMed ID: 27765556
[TBL] [Abstract][Full Text] [Related]
2. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ;
Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957
[TBL] [Abstract][Full Text] [Related]
3. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.
Kwon HM; Lynn MJ; Turan TN; Derdeyn CP; Fiorella D; Lane BF; Montgomery J; Janis LS; Rumboldt Z; Chimowitz MI;
JAMA Neurol; 2016 Jan; 73(1):36-42. PubMed ID: 26618534
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.
Waters MF; Hoh BL; Lynn MJ; Kwon HM; Turan TN; Derdeyn CP; Fiorella D; Khanna A; Sheehan TO; Lane BF; Janis S; Montgomery J; Chimowitz MI;
JAMA Neurol; 2016 Mar; 73(3):308-15. PubMed ID: 26747792
[TBL] [Abstract][Full Text] [Related]
5. Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Derdeyn CP; Turan TN; Fiorella D; Lane BF; Janis LS; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Torbey MT; Zaidat OO; Rumboldt Z; Cloft HJ;
N Engl J Med; 2011 Sep; 365(11):993-1003. PubMed ID: 21899409
[TBL] [Abstract][Full Text] [Related]
6. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
[TBL] [Abstract][Full Text] [Related]
7. Stenting versus aggressive medical therapy for intracranial arterial stenosis: more harm than good.
Al Hasan M; Murugan R
Crit Care; 2012 May; 16(3):310. PubMed ID: 22574950
[TBL] [Abstract][Full Text] [Related]
8. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
[TBL] [Abstract][Full Text] [Related]
9. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).
Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI;
Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting.
Zhao J; Li X; Chi LX; Ma BW; Du YH; Chen GS; Zhou HD; Li JC; Jiang XJ; Yang QW; Zhao XF; Yao XF
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):479-485. PubMed ID: 29056405
[TBL] [Abstract][Full Text] [Related]
11. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP;
J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789
[TBL] [Abstract][Full Text] [Related]
12. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.
Turan TN; Al Kasab S; Nizam A; Lynn MJ; Harrell J; Derdeyn CP; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI;
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):801-805. PubMed ID: 29169967
[TBL] [Abstract][Full Text] [Related]
14. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
[TBL] [Abstract][Full Text] [Related]
15. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
[TBL] [Abstract][Full Text] [Related]
16. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
[TBL] [Abstract][Full Text] [Related]
17. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
[TBL] [Abstract][Full Text] [Related]
18. Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.
Yu SC; Cheng HK; Cheng PW; Lui WM; Leung KM; Tan CB; Pang KY; Wong GK; Cheung YL; Lee R; Wong YC; Wong CK; Kwok JC;
Hong Kong Med J; 2013 Feb; 19(1):69-73. PubMed ID: 23378358
[TBL] [Abstract][Full Text] [Related]
19. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.
Kim JK; Ahn JY; Lee BH; Chung YS; Chung SS; Kim OJ; Kim WC; Joo JY
J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):847-51. PubMed ID: 15145998
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).
Fiorella D; Derdeyn CP; Lynn MJ; Barnwell SL; Hoh BL; Levy EI; Harrigan MR; Klucznik RP; McDougall CG; Pride GL; Zaidat OO; Lutsep HL; Waters MF; Hourihane JM; Alexandrov AV; Chiu D; Clark JM; Johnson MD; Torbey MT; Rumboldt Z; Cloft HJ; Turan TN; Lane BF; Janis LS; Chimowitz MI;
Stroke; 2012 Oct; 43(10):2682-8. PubMed ID: 22984008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
